Metformin + Placebo
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Metabolic Complications
Conditions
Metabolic Complications
Trial Timeline
Aug 1, 2007 → Aug 1, 2011
NCT ID
NCT00682448About Metformin + Placebo
Metformin + Placebo is a approved stage product being developed by Eli Lilly for Metabolic Complications. The current trial status is completed. This product is registered under clinical trial identifier NCT00682448. Target conditions include Metabolic Complications.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00682448 | Approved | Completed |
Competing Products
20 competing products in Metabolic Complications